Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1222]

Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer

Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer

International collaboration for genome analysis leads to clues about rare cancer

International collaboration for genome analysis leads to clues about rare cancer

Breakthrough technology offers new treatment for patients with hard-to-reach tumours

Breakthrough technology offers new treatment for patients with hard-to-reach tumours

Discovery of cancer gene may predict survival in patients with mouth cancers

Discovery of cancer gene may predict survival in patients with mouth cancers

HPV vaccination expected to reduce cancer in all races, may not eliminate all disparities

HPV vaccination expected to reduce cancer in all races, may not eliminate all disparities

Discovery of drug target in rare, lethal glandular cancer

Discovery of drug target in rare, lethal glandular cancer

AACR 2016 highlights

AACR 2016 highlights

AACR 2016: Nivolumab improved survival for patients with head and neck squamous cell carcinoma

AACR 2016: Nivolumab improved survival for patients with head and neck squamous cell carcinoma

Rare paediatric cancer successfully treated with new targeted therapy

Rare paediatric cancer successfully treated with new targeted therapy

New preclinical data show combination of lenvatinib and everolimus yields greater anti-tumour activity than either agent alone in kidney cancer

New preclinical data show combination of lenvatinib and everolimus yields greater anti-tumour activity than either...

More from ecancer